PIM
Ponoi II Management Portfolio holdings
AUM
$38.3M
This Quarter Return
-8.05%
1 Year Return
-32.02%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$55.1M
AUM Growth
+$55.1M
(-18%)
Cap. Flow
-$6.79M
Cap. Flow
% of AUM
-12.33%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Nurix Therapeutics
NRIX
|
$6.79M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $23M | 41.78% |
1,298,908
| – | – |
|
2
Revolution Medicines
RVMD
$7.1B
| $17.2M | 31.32% |
685,011
| – | – |
|
|
3
Nurix Therapeutics
NRIX
$714M
| $9.47M | 17.2% |
327,123
-234,451
| -42% | -$6.79M |
|
4
RAPT Therapeutics
RAPT
$188M
| $5.34M | 9.7% |
145,401
| – | – |
|